Compare FIP & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FIP | EMBC |
|---|---|---|
| Founded | 2021 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 567.5M | 602.3M |
| IPO Year | 2021 | 2021 |
| Metric | FIP | EMBC |
|---|---|---|
| Price | $6.41 | $10.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $11.00 | ★ $18.50 |
| AVG Volume (30 Days) | 880.5K | ★ 893.2K |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | 1.90% | ★ 5.84% |
| EPS Growth | N/A | ★ 20.90 |
| EPS | N/A | ★ 0.74 |
| Revenue | ★ $331,497,000.00 | N/A |
| Revenue This Year | $60.92 | $1.17 |
| Revenue Next Year | $57.57 | N/A |
| P/E Ratio | ★ N/A | $13.89 |
| Revenue Growth | ★ 3.44 | N/A |
| 52 Week Low | $3.10 | $9.20 |
| 52 Week High | $7.93 | $15.55 |
| Indicator | FIP | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 62.03 | 41.86 |
| Support Level | $5.94 | $10.27 |
| Resistance Level | $6.72 | $10.87 |
| Average True Range (ATR) | 0.33 | 0.64 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 96.33 | 11.76 |
FTAI Infrastructure Inc is engaged in five segments; Railroad segment includes five freight railroads and one switching company that provide rail service to certain manufacturing and production facilities, the Jefferson Terminal segment consists of a multi-modal crude oil and refined products terminal and other related assets. Repauno segment consists of a 1,630-acre deep-water port located along the Delaware River with an underground storage cavern, a new multipurpose dock, a rail-to-ship transloading system, and multiple industrial development opportunities. Power and Gas segment is comprised of an equity method investment in Long Ridge, and Sustainability and Energy Transition segment is comprised of Aleon/Gladieux, Clean Planet, and CarbonFree.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.